在2型糖尿病中优化风险参数:视网膜视角的前景
Sarita Jacob1, George I Varughese2
1University Hospitals Birmingham NHS Foundation Trust, Birmingham, B15 2GW, UK.
Clinical medicine (London, England)
|February 18, 2024
概括
糖尿病视网膜病变和病变共享的机制. 虽然一些糖尿病药物最初会使视网膜病变恶化,但较新的-葡萄糖辅运输体-2抑制剂可以避免这种情况. 研究正在探索保护转化到视网膜.
科学领域:
- 内分泌学 在内分泌学.
- 眼科医生 眼科 眼科
- 腎臟病學 (nephrology) 是一種醫學專業.
背景情况:
- 糖尿病视网膜病变和病变共享潜在的病理生理机制.
- 低于最佳的血糖控制与这些微血管并发症的严重程度相关.
- -葡萄糖共载体-2抑制剂 (SGLT2i) 和类似葡萄糖-1受体激动剂 (GLP-1RA) 证明了对的保护.
研究的目的:
- 探索SGLT2i和GLP-1RA对糖尿病视网膜病变的保护性能的适用性.
- 讨论糖尿病视网膜病变早期恶化的悖论,并改善血糖控制.
- 调查为什么新的SGLT2i可能不会表现出这种现象.
主要方法:
- 文献综述和关于糖尿病微血管并发症现有研究的讨论.
- 对关联脏和视网膜保护的病理生理机制的分析.
- 关于血糖控制强化和糖尿病视网膜病变进展的临床观察的探索.
主要成果:
- 突然改善血糖控制可以暂时恶化先前存在的糖尿病视网膜病变,特别是在糖尿病持续时间较长,HbA1c较高,快速降低葡萄糖和加强治疗的情况下.
- 这种矛盾的进展在较新的SGLT2抑制剂中较少见.
- 共享的机制表明,脏保护策略可能会转化为视网膜.
结论:
- SGLT2i和GLP-1RA的脏保护作用需要对糖尿病视网膜病变进行调查.
- 了解暂时恶化的现象对于在血糖控制强化期间管理糖尿病视网膜病变至关重要.
- 未来的研究应该专注于将脏保护机制转化为糖尿病患者的视网膜健康.
相关概念视频
01:22Diabetes Mellitus: Type 2 and Gestational
2.4K
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
2.4K
01:15Diabetes: Management and Pharmacotherapy
283
The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
283
01:15Diabetes: Symptoms, Diagnosis, and Complications
539
For most patients, experiencing several weeks of polyuria, polydipsia, fatigue, and significant weight loss may indicate the presence of diabetes. Furthermore, adults displaying the phenotypic appearance of type 2 diabetes (particularly those who are obese and not initially insulin-requiring), may have islet cell autoantibodies, suggesting autoimmune-mediated β cell destruction and a diagnosis of latent autoimmune diabetes of adults (LADA). The categorization of glucose homeostasis is...
539
01:17Factors Affecting Renal Clearance: Renal Impairment
94
Renal dysfunction significantly impairs the renal clearance of drugs, leading to potential complications in drug therapy. Renal failure, which can be caused by various factors, poses a significant challenge in the elimination of drugs from the body.
One condition associated with renal failure is uremia. Uremia is characterized by impaired glomerular filtration and fluid accumulation in the body. This condition hinders the renal clearance of drugs, resulting in drug accumulation and potential...
One condition associated with renal failure is uremia. Uremia is characterized by impaired glomerular filtration and fluid accumulation in the body. This condition hinders the renal clearance of drugs, resulting in drug accumulation and potential...
94
01:22Diabetes Mellitus: Overview and Type I Subtype
2.6K
Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
2.6K
01:11Renal Failure: Dose Adjustments
89
In patients with renal impairment, drugs undergo significant changes in their pharmacokinetics, which require dosage adjustments to ensure safe and effective therapy.
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
89